New Findings on Chronic Fatigue Syndrome

Researchers from the University of Edinburgh are unveiling significant differences in the blood of individuals with ME, also known as chronic fatigue syndrome, compared to healthy individuals. These findings might lead to a potentially revolutionary diagnostic test.

According to Professor Chris Ponting, the perception that ME/CFS is merely psychological has persisted for too long. He emphasizes, “It’s not in their heads; we can see physiological changes in their blood.” However, there are critics who argue that the implications of the study have been exaggerated.

The study analyzed data from the UK Biobank, which encompasses a vast health database with over half a million participants. Researchers compared blood samples from 1,455 ME/CFS patients to 131,000 healthy counterparts, revealing that the differences detected were largely independent of activity levels.

Dr. Sjoerd Beentjes shared insights on BBC Radio’s Good Morning Scotland, asserting that their evidence suggests ME is a condition measurable in the blood. “Perhaps previous beliefs need to be reconsidered,” he added. “It’s not simply a result of inactivity, and we hope this research will help those whose symptoms have been dismissed.”

Understanding ME Symptoms

Myalgic encephalomyelitis (ME), or chronic fatigue syndrome (CFS), is estimated to affect around 50,000 individuals in Scotland alone. The largest biological study of ME/CFS to date has identified consistent blood biomarkers linked to chronic inflammation, insulin resistance, and liver issues.

The hallmark symptom of this condition is post-exertional malaise (PEM), characterized by a marked increase in fatigue following even minimal physical or mental exertion. Other reported symptoms include pain, cognitive fog, and unrelenting tiredness, which does not improve with rest. Currently, the causes of ME are unclear, and there is no specific diagnostic test or cure available.

Dr. Beentjes pointed out that ME has a clear gender bias, with approximately three women affected for every man.

The team at Edinburgh carefully examined over 3,000 blood biomarkers, controlling for differing factors like age, sex, and activity levels. They were able to replicate their results using data from the US as well. Professor Ponting reiterated, “For far too long, people suffering from ME/CFS have been told it’s all in their heads. The evidence we see indicates otherwise.” He believes this data should help eliminate any misconceptions linking ME/CFS to deconditioning or simple fatigue intolerance.

Nevertheless, skepticism remains among some experts. Alan Carson, a neuropsychiatry professor at Edinburgh, noted that while the study demonstrates ME/CFS is a real condition, the claim connecting blood markers to the validity of the condition as ‘not all in your head’ overlooks the complexity that both mental and physical illnesses might share.

Meanwhile, Kevin McConway, an emeritus professor of applied statistics at the Open University, acknowledges the research’s importance but emphasizes the necessity of caution in interpreting its findings. “There’s much more work to be done,” he cautions.